On July 20, 2023, Chiome Bioscience Inc. closed the transaction.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
126 JPY | +1.61% | +1.61% | -6.67% |
04-01 | Chiome Bioscience Cancels License Agreements with ADC Therapeutics | MT |
02-13 | Chiome Bioscience Inc. Announces Entrustment Agreement with Takeda Pharmaceutical Company Limited | CI |
1st Jan change | Capi. | |
---|---|---|
-6.67% | 45.11M | |
+22.56% | 46.4B | |
-1.51% | 41.75B | |
+48.83% | 41.37B | |
-3.42% | 29.71B | |
+10.13% | 26.01B | |
-20.44% | 19.52B | |
+26.45% | 12.43B | |
-0.14% | 12.18B | |
-0.47% | 12.13B |
- Stock Market
- Equities
- 4583 Stock
- News Chiome Bioscience Inc.
- Chiome Bioscience Inc. announced that it has received ¥13.49304 million in funding from Barclays Bank PLC (Tokyo Branch), Growth Capital, Inc.